Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Pharmacology and Therapeutics|March 1, 1995
Dipyrone and diclofenac do not influence creatinine-clearance, inulin-clearance or PAH-clearance in healthy male volunteersK Farker, N Nassr, F Huck, et al.
European Journal of Clinical Investigation|March 21, 1998
Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery diseaseD Reinhardt, H H Sigusch, S F Vogt, et al.
Die Pharmazie|May 1, 1993
[Hemodynamic effects and adverse effects of the anti-arrhythmic substance AWD-G256 in man]H Volkmann, G Dannberg, H Kühnert, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|October 23, 1998
Impact of CYP2E1 genotype in renal cell and urothelial cancer patientsK Farker, M H Lehmann, B Oelschlägel, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 10, 2000
Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control populationK Farker, M H Lehmann, R Kästner, et al.
Archives of Orthopaedic and Trauma Surgery|June 18, 2003
Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healingA Beck, G Krischak, T Sorg, et al.
Die Pharmazie|February 23, 2000
A common variant of the angiotensinogen gene and the risk of coronary artery disease in a German populationD Reinhardt, H H Sigusch, S F Vogt, et al.
Die Pharmazie|May 1, 1993
[Clinical-electrophysiologic studies on the actions of the anti-arrhythmic substance AWD-G256 in man]H Volkmann, A Hoffmann, H Kühnert, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 6, 1998
CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populationsK Farker, M H Lehmann, R Kästner, et al.
Prostaglandins|November 28, 1997
Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal womenK Farker, H Schweer, R Vollandt, et al.
Pageof 3